Skip to main content

Advertisement

SpringerLink
Log in

New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Background and purpose

It is now known that post-transplant graft function after deceased-donor liver transplantation and living-donor liver transplantation (LDLT) differ; however, there is no report assessing the relationship between graft function and the development of new-onset diabetes mellitus after transplantation (NODAT). We conducted this study to identify the predictive risk factors for NODAT, including graft function after LDLT.

Methods

The subjects of this study were 175 adult recipients who underwent LDLT at Kyoto University Hospital between 2006 and 2010, and survived for more than 3 months (median observation period, 1046 days).

Results

The 1-, 2-, and 3-year incidences of NODAT after LDLT were 26.1, 32.0, and 33.4%, respectively. Pre-transplant diabetes was associated with poor survival (p = 0.0048), whereas NODAT was not associated with patient survival. In the multivariate analysis, recipient age ≥40, a tacrolimus trough level ≥8 ng/mL 3 months after LDLT, and cholinesterase (ChE) <185 IU/L 3 months after LDLT were the independent risk factors for NODAT.

Conclusions

Poor graft synthetic function 3 months after LDLT as well as older age of the recipient and a higher tacrolimus concentration were strongly associated with NODAT development after LDLT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):SS3–24.

  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.

    Article  CAS  PubMed  Google Scholar 

  3. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol. 1996;25(1):64–71.

    Article  CAS  PubMed  Google Scholar 

  4. Kuo HT, Sampaio MS, Ye X, Reddy P, Martin P, Bunnapradist S. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010;89(9):1134–40.

    Article  PubMed  Google Scholar 

  5. Oufroukhi L, Kamar N, Muscari F, Lavayssiere L, Guitard J, Ribes D, et al. Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation. 2008;85(10):1436–42.

    Article  PubMed  Google Scholar 

  6. Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13(1):136–44.

    Article  PubMed  Google Scholar 

  7. Van Laecke S, Desideri F, Geerts A, Van Vlierberghe H, Berrevoet F, Rogiers X, et al. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Liver Transplant. 2010;16(11):1278–87.

    Article  Google Scholar 

  8. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C. Transplant Proc. 2006;38(9):2989–92.

    Article  CAS  PubMed  Google Scholar 

  9. Zhao J, Yan L, Li B, Zeng Y, Wen T, Wang W, et al. Diabetes mellitus after living donor liver transplantation: data from mainland China. Transpl Proc. 2009;41(5):1756–60.

    Article  CAS  Google Scholar 

  10. Kim YK, Lee KW, Kim SH, Cho SY, Han SS, Park SJ. Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation. World J Surg. 2012;36(10):2443–8.

    Article  PubMed  Google Scholar 

  11. Harada N, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Aoki T, et al. New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience. J Hepatobiliary Pancreat Sci. 2013;20(6):634–8.

    Article  PubMed  Google Scholar 

  12. Honda M, Asonuma K, Hayashida S, Suda H, Ohya Y, Lee KJ, et al. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients. Clin Transplant. 2013;27(3):426–35.

    Article  PubMed  Google Scholar 

  13. Abe T, Onoe T, Tahara H, Tashiro H, Ishiyama K, Ide K, et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. Transplant Proc. 2014;46(3):865–9.

    Article  CAS  PubMed  Google Scholar 

  14. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, et al. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transplant. 2007;13(1):122–9.

    Article  Google Scholar 

  15. Soyama A, Eguchi S. The current status and future perspectives of organ donation in Japan: learning from the systems in other countries. Surg Today. 2016;46(4):387–92.

    Article  PubMed  Google Scholar 

  16. Hammad A, Kaido T, Ogawa K, Fujimoto Y, Uemura T, Mori A, et al. Liver transplantation for advanced hepatocellular carcinoma in patients with Child–Pugh A and B. Surg Today. 2016;46(2):248–54.

    Article  CAS  PubMed  Google Scholar 

  17. Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Nishizawa T, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg. 1993;217(1):82–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation. 1996;61(2):247–52.

    Article  CAS  PubMed  Google Scholar 

  19. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008;47(1):143–52.

    Article  PubMed  Google Scholar 

  20. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2009;9(6):1406–13.

    Article  CAS  PubMed  Google Scholar 

  21. Brown SS, Kalow W, Pilz W, Whittaker M, Woronick CL. The plasma cholinesteerases: a new perspective. Adv Clin Chem. 1981;22:1–123.

    Article  CAS  PubMed  Google Scholar 

  22. Turecky L, Kupcova V, Mojto V, Smutny M, Uhlikova E, Vozar I. Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus. Bratisl Lek Listy. 2005;106(8–9):266–9.

    CAS  PubMed  Google Scholar 

  23. Meng F, Yin X, Ma X, Guo XD, Jin B, Li H. Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep. 2013;1(2):265–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Koetting M, Luer B, Efferz P, Paul A, Minor T. Optimal time for hypothermic reconditioning of liver grafts by venous systemic oxygen persufflation in a large animal model. Transplantation. 2011;91(1):42–7.

    Article  PubMed  Google Scholar 

  25. Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol. 2011;17(48):5240–5.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation. 2006;82(12):1625–8.

    Article  PubMed  Google Scholar 

  27. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, et al. New onset diabetes mellitus in living donor versus deceased donor liver transplant recipients: analysis of the UNOS/OPTN database. J Transplant. 2013;2013:269096.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008;134(2):416–23.

    Article  CAS  PubMed  Google Scholar 

  29. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4(4):583–95.

    Article  PubMed  Google Scholar 

  30. Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, et al. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol. 2016;22(6):2133–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complicat. 2006;20(2):113–20.

    Article  PubMed  Google Scholar 

  32. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc. 2000;75(4):355–9.

    Article  CAS  PubMed  Google Scholar 

  33. Chen T, Jia H, Li J, Chen X, Zhou H, Tian H. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies. Transpl Int. 2009;22(4):408–15.

    Article  PubMed  Google Scholar 

  34. Parolin MB, Zaina FE, Araujo MV, Kupka E, Coelho JC. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection. Transplant Proc. 2004;36(9):2776–7.

    Article  CAS  PubMed  Google Scholar 

  35. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001;72(6):1066–72.

    Article  CAS  PubMed  Google Scholar 

  36. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transplant. 2004;10(3):349–55.

    Article  Google Scholar 

  37. Li Z, Sun F, Hu Z, Xiang J, Zhou J, Yan S, et al. New-onset diabetes mellitus in liver transplant recipients with hepatitis C: analysis of the national database. Transplant Proc. 2016;48(1):138–44.

    Article  CAS  PubMed  Google Scholar 

  38. Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, et al. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J Biol Chem. 2002;277(27):24484–9.

    Article  CAS  PubMed  Google Scholar 

  39. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994;21(6):1135–9.

    Article  CAS  PubMed  Google Scholar 

  40. Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2006;6(8):1922–9.

    Article  CAS  PubMed  Google Scholar 

  41. Garcia-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol. 2009;8(1):13–20.

    CAS  PubMed  Google Scholar 

  42. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology. 2000;31(3):694–703.

    Article  CAS  PubMed  Google Scholar 

  43. Hoehn RS, Singhal A, Wima K, Sutton JM, Paterno F, Steve Woodle E, et al. Effect of pretransplant diabetes on short-term outcomes after liver transplantation: A National cohort study. Liver Int. 2015;35(7):1902–9.

    Article  PubMed  Google Scholar 

  44. Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668–85.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima & Shinji Uemoto

Authors
  1. Shintaro Yagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshimi Kaido
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taku Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atsushi Yoshizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideaki Okajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinji Uemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shintaro Yagi.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yagi, S., Kaido, T., Iida, T. et al. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surg Today 47, 733–742 (2017). https://doi.org/10.1007/s00595-016-1444-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-016-1444-z

Keywords

Search

Navigation